-- シンガポール証券取引所への火曜日の提出書類によると、UltraGreen.ai（SGX:ULG）は、インドシアニングリーン注射剤「Verdye」についてシンガポールで規制当局の承認を取得した。 この承認により、同社は蛍光誘導技術の普及促進の一環として、商業化活動を加速させ、地元の医療機関との提携を拡大することができる。 この技術は、複数の外科手術に利用されている。 このヘルスケア情報企業の株価は、火曜日の午前中の取引で5%以上下落した。
Related Articles
Asia
Mahindra Holidays & Resorts India Names CFO
Mahindra Holidays & Resorts India (NSE:MHRIL, BOM:533088) has appointed Rajiv Vimal as the chief financial officer and key managerial personnel of the company with effect from July 1, according to a Tuesday filing to the Indian stock exchanges.He takes over from Vimal Agarwal, who will resign as chief financial officer and key managerial personnel of the company, with effect from June 30, to transition to a new role within the Mahindra Group.The company's shares were down nearly 1% in recent trade.
$BOM:533088$NSE:MHRIL
Asia
Jefferies Adjusts Cholamandalam Investment and Finance's Price Target to INR1,960 From INR2,040, Keeps at Buy
Cholamandalam Investment and Finance (NSE:CHOLAFIN, BOM:511243) has an average rating of overweight and mean price target of 1,811.95 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$BOM:511243$NSE:CHOLAFIN
Asia
Jefferies Adjusts Hyundai Motor India's Price Target to INR1,600 from INR1,900, Keeps at Underperform
Hyundai Motor India (NSE:HYUNDAI, BOM:544274) has an average rating of overweight and mean price target of 2,247.41 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$BOM:544274$NSE:HYUNDAI